The fetal programming effect of maternal immune activation (MIA) on the offspring’s immune system
Seminars in Immunopathology · 2024
DOI: 10.1007/s00281-024-01023-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Immunopathology, 2024. Verfasst von Naomi Hofsink und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. n.hofsink@umcg.nl. Hauptthemen laut MEDLINE: Prenatal Exposure Delayed Effects, Immune System, Fetal Development, COVID-19. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NWO domain Applied and Engineered Sciences, Danone Research and Innovation.
Abstract (Originalsprache)
The first 1000 days of life is a critical period of development in which adverse circumstances can have long-term consequences for the child’s health. Maternal immune activation is associated with increased risk of neurodevelopmental disorders in the child. Aberrant immune responses have been reported in individuals with neurodevelopmental disorders. Moreover, lasting effects of maternal immune activation on the offspring’s immune system have been reported. Taken together, this indicates that the effect of maternal immune activation is not limited to the central nervous system. Here, we explore the impact of maternal immune activation on the immune system of the offspring. We first describe the development of the immune system and provide an overview of reported alterations in the cytokine profiles, immune cell profiles, immune cell function, and immune induction in pre-clinical models. Additionally, we highlight recent research on the impact of maternal COVID-19 exposure on the neonatal immune system and the potential health consequences for the child. Our review shows that maternal immune activation alters the offspring’s immune system under certain conditions, but the reported effects are conflicting and inconsistent. In general, epigenetic modifications are considered the mechanism for fetal programming. The available data was insufficient to identify specific pathways that may contribute to immune programming. As a consequence of the COVID-19 pandemic, more research now focuses on the possible health effects of maternal immune activation on the offspring. Future research addressing the offspring’s immune response to maternal immune activation can elucidate specific pathways that contribute to fetal immune programming and the long-term health effects for the offspring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. n.hofsink@umcg.nl.
- Department of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
- Department of Obstetrics and Gynaecology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Carl von Ossietzky Universität Oldenburg School VI - School of Medicine and Health Sciences, Department of Paediatrics, Section of Neonatology, and Research Centre Neurosensory Science, Oldenburg, Germany.
ORCID-Profile: Torsten Plösch
Förderung
- NWO domain Applied and Engineered Sciences
- Danone Research and Innovation
Zitieren
APA
Hofsink, N., Groenink, L., & Plösch, T. (2024). The fetal programming effect of maternal immune activation (MIA) on the offspring’s immune system. Seminars in Immunopathology. https://doi.org/10.1007/s00281-024-01023-8
Vancouver
Hofsink N, Groenink L, Plösch T. The fetal programming effect of maternal immune activation (MIA) on the offspring’s immune system. Seminars in Immunopathology. 2024. doi:10.1007/s00281-024-01023-8
BibTeX
@article{Hofsink2024,
author = {Hofsink, Naomi and Groenink, Lucianne and Plösch, Torsten},
title = {The fetal programming effect of maternal immune activation (MIA) on the offspring’s immune system},
journal = {Seminars in Immunopathology},
year = {2024},
doi = {10.1007/s00281-024-01023-8}
}
EUVIMED